About XenoTherapeutics, Inc.
XenoTherapeutics is a United States–based biotechnology company focused on the development of xenogeneic and immunotherapy-based treatments for cancer and other diseases. The company’s research activities center on genetically engineered porcine cells and tissues designed for use in therapeutic applications, including cell-based immunotherapies and transplantation-related technologies. XenoTherapeutics conducts research and development activities aimed at advancing novel treatment approaches through preclinical and early-stage clinical programs. XenoTherapeutics was founded in 2016 and is headquartered in Columbia, Missouri, United States.